Fidelity Investments’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-1,997,330
| Closed | -$280M | – | 4492 |
|
|
2018
Q4 | $280M | Buy |
1,997,330
+86,980
| +5% | +$13.2M | 0.04% | 465 |
|
|
2018
Q3 | $326M | Sell |
1,910,350
-390,352
| -17% | -$65.6M | 0.04% | 472 |
|
|
2018
Q2 | $399M | Sell |
2,300,702
-2,034,169
| -47% | -$306M | 0.05% | 395 |
|
|
2018
Q1 | $500M | Sell |
4,334,871
-155,754
| -3% | -$16.6M | 0.06% | 339 |
|
|
2017
Q4 | $378M | Buy |
4,490,625
+12,721
| +0.3% | +$1.06M | 0.04% | 439 |
|
|
2017
Q3 | $413M | Buy |
4,477,904
+83,077
| +2% | +$6.45M | 0.05% | 394 |
|
|
2017
Q2 | $352M | Buy |
4,394,827
+472,814
| +12% | +$26.2M | 0.04% | 444 |
|
|
2017
Q1 | $165M | Buy |
3,922,013
+670,306
| +21% | +$27.6M | 0.02% | 775 |
|
|
2016
Q4 | $104M | Buy |
3,251,707
+2,058
| +0.1% | +$52.8K | 0.01% | 971 |
|
|
2016
Q3 | $85.1M | Buy |
3,249,649
+49,793
| +2% | +$1.3M | 0.01% | 1055 |
|
|
2016
Q2 | $74.2M | Buy |
3,199,856
+252,197
| +9% | +$6.28M | 0.01% | 1105 |
|
|
2016
Q1 | $80.6M | Buy |
2,947,659
+13,294
| +0.5% | +$278K | 0.01% | 1065 |
|
|
2015
Q4 | $83.5M | Buy |
2,934,365
+2,704,079
| +1,174% | +$72.6M | 0.01% | 1040 |
|
|
2015
Q3 | $4.03M | Buy |
+230,286
| New | +$4.51M | ﹤0.01% | 2238 |
|
Other funds holding LOXO
Fidelity Investments's LOXO Position: Q1 2019 in Review
Fidelity Investments sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 1,997,330 shares — an estimated $280M sold.
Fidelity Investments first reported a position in LOXO in Q3 2015 and held it in 14 quarters. The position peaked at $500M in Q1 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.
- Fidelity Investments reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
- Fidelity Investments sold 1,997,330 Loxo Oncology, Inc shares in Q1 2019, an estimated $280M.
- Fidelity Investments first reported a position in Loxo Oncology, Inc in Q3 2015 and held it in 14 quarters.
- Fidelity Investments's Loxo Oncology, Inc position peaked at $500M in Q1 2018.
- 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.
Based on Fidelity Investments's 13F filing for Q1 2019, filed 13 May 2019.